JP2023503850A5 - - Google Patents
Info
- Publication number
- JP2023503850A5 JP2023503850A5 JP2022527987A JP2022527987A JP2023503850A5 JP 2023503850 A5 JP2023503850 A5 JP 2023503850A5 JP 2022527987 A JP2022527987 A JP 2022527987A JP 2022527987 A JP2022527987 A JP 2022527987A JP 2023503850 A5 JP2023503850 A5 JP 2023503850A5
- Authority
- JP
- Japan
- Prior art keywords
- vector construct
- c1ei
- composition
- functional
- construct according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962935359P | 2019-11-14 | 2019-11-14 | |
| US62/935,359 | 2019-11-14 | ||
| US202063016365P | 2020-04-28 | 2020-04-28 | |
| US63/016,365 | 2020-04-28 | ||
| PCT/US2020/060337 WO2021097157A1 (en) | 2019-11-14 | 2020-11-13 | Treatment of hereditary angioedema with liver-specific gene therapy vectors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023503850A JP2023503850A (ja) | 2023-02-01 |
| JP2023503850A5 true JP2023503850A5 (cg-RX-API-DMAC7.html) | 2023-11-20 |
Family
ID=73834586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022527987A Pending JP2023503850A (ja) | 2019-11-14 | 2020-11-13 | 肝臓特異的遺伝子療法ベクターによる遺伝性血管浮腫の治療 |
Country Status (14)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230078805A (ko) | 2020-11-02 | 2023-06-02 | 바이오마린 파머수티컬 인크. | 아데노-연관 바이러스의 농축 공정 |
| KR20230136147A (ko) * | 2021-01-27 | 2023-09-26 | 스파크 테라퓨틱스, 인코포레이티드 | 유전성 혈관부종을 치료하기 위한 조성물 및 방법 |
| BR112023026523A2 (pt) * | 2021-06-17 | 2024-03-05 | Meiragtx Uk Ii Ltd | Métodos para fabricar aav |
| TW202332472A (zh) | 2021-10-01 | 2023-08-16 | 美商拜奧馬林製藥公司 | 利用aav基因療法載體進行之遺傳性血管水腫治療及治療性調配物 |
| CN117947040A (zh) | 2022-10-31 | 2024-04-30 | 苏州荷光科汇生物科技有限公司 | 用于目的基因的表达盒及其应用 |
| US20260207786A1 (en) * | 2024-11-18 | 2026-07-23 | Sonothera, Inc. | Methods and compositions for improved delivery via ultrasound |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0127839B1 (en) | 1983-05-27 | 1992-07-15 | THE TEXAS A&M UNIVERSITY SYSTEM | Method for producing a recombinant baculovirus expression vector |
| US4745051A (en) | 1983-05-27 | 1988-05-17 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
| DK518384A (da) | 1984-01-31 | 1985-07-01 | Idaho Res Found | Vektor til fremstilling af et gen-produkt i insektceller, fremgangsmaade til dens fremstilling samt dens anvendelse |
| US6204059B1 (en) | 1994-06-30 | 2001-03-20 | University Of Pittsburgh | AAV capsid vehicles for molecular transfer |
| US7323324B2 (en) | 2001-10-16 | 2008-01-29 | National Institute Of Advanced Industrial Science And Technology | N-Acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor |
| US6723551B2 (en) | 2001-11-09 | 2004-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Production of adeno-associated virus in insect cells |
| CN103589692B (zh) | 2001-11-13 | 2018-07-24 | 宾夕法尼亚大学托管会 | 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法 |
| WO2003074714A1 (en) | 2002-03-05 | 2003-09-12 | Stichting Voor De Technische Wetenschappen | Baculovirus expression system |
| AU2003221733A1 (en) * | 2002-04-17 | 2003-11-03 | University Of Florida Research Foundation, Inc. | Improved raav vectors |
| US7943379B2 (en) | 2008-04-30 | 2011-05-17 | Nationwide Children's Hospital, Inc. | Production of rAAV in vero cells using particular adenovirus helpers |
| BR112014020325A2 (pt) | 2012-02-17 | 2017-08-08 | Childrens Hospital Philadelphia | composições de vetor do aav e métodos para a transferência de gene para as células, órgãos e tecidos |
| NZ716102A (en) * | 2013-07-22 | 2021-12-24 | The Children’S Hospital Of Philadelphia | Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues |
| ES2813698T3 (es) * | 2013-09-12 | 2021-03-24 | Biomarin Pharm Inc | Vectores de AAV que comprenden un gen que codifica el factor VIII |
| KR20180014051A (ko) * | 2015-05-28 | 2018-02-07 | 코넬 유니버시티 | 혈관 부종 치료제로서의 아데노-관련 바이러스 매개 c1e1의 전달 |
| JP6994018B2 (ja) | 2016-07-26 | 2022-01-14 | バイオマリン ファーマシューティカル インコーポレイテッド | 新規アデノ随伴ウイルスキャプシドタンパク質 |
| EP3740581A4 (en) * | 2018-01-16 | 2021-10-27 | CLS Therapeutics Limited | TREATMENT OF DISEASES BY LIVER EXPRESSION OF AN ENZYME WITH DESOXYRIBONUCLEASE (DNASE) ACTIVITY |
| JP2022505876A (ja) * | 2018-10-26 | 2022-01-14 | フリーイェ・ユニヴェルシテイト・ブリュッセル | 遺伝子治療を向上させる新しいツール及びその使用 |
| WO2021081280A1 (en) * | 2019-10-23 | 2021-04-29 | Shire Human Genetic Therapies, Inc. | Adeno-associated virus vectors based gene therapy for hereditary angioedema |
-
2020
- 2020-11-13 US US17/777,690 patent/US20230340078A1/en not_active Abandoned
- 2020-11-13 CN CN202080087888.0A patent/CN114829391A/zh active Pending
- 2020-11-13 AU AU2020384294A patent/AU2020384294A1/en not_active Abandoned
- 2020-11-13 JP JP2022527987A patent/JP2023503850A/ja active Pending
- 2020-11-13 KR KR1020227019436A patent/KR20220098210A/ko not_active Ceased
- 2020-11-13 TW TW109139830A patent/TW202128733A/zh unknown
- 2020-11-13 WO PCT/US2020/060337 patent/WO2021097157A1/en not_active Ceased
- 2020-11-13 EP EP20824369.1A patent/EP4058475A1/en not_active Withdrawn
- 2020-11-13 BR BR112022009279A patent/BR112022009279A2/pt not_active IP Right Cessation
- 2020-11-13 MX MX2022005869A patent/MX2022005869A/es unknown
- 2020-11-13 CA CA3161154A patent/CA3161154A1/en active Pending
-
2022
- 2022-04-29 CO CONC2022/0005641A patent/CO2022005641A2/es unknown
- 2022-05-03 IL IL292717A patent/IL292717A/en unknown
- 2022-05-13 CL CL2022001260A patent/CL2022001260A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220331409A1 (en) | Factor ix gene therapy | |
| US20240109938A1 (en) | Recombinant aav1, aav5, and aav6 capsid mutants and uses thereof | |
| US10308957B2 (en) | rAAV vectors and methods for transduction of photoreceptors and RPE cells | |
| US11338045B2 (en) | Adeno-associated virus vector delivery of a fragment of micro-dystrophin to treat muscular dystrophy | |
| US12612432B2 (en) | AAV capsid variants for gene therapy | |
| SG11202111400TA (en) | Compositions useful for treatment of pompe disease | |
| US20240102050A1 (en) | Compositions and methods for treatment of neurological disorders | |
| EP3773748A1 (en) | Bicistronic aav vectors encoding hexosaminidase alpha and beta-subunits and uses thereof | |
| CA3207268A1 (en) | Compositions and methods for treating hereditary angioedema | |
| WO2021231575A1 (en) | Immunosuppressive agents and viral delivery re-dosing methods for gene therapy | |
| Chen | Adeno-associated virus vectors for human gene therapy | |
| US11517631B2 (en) | Factor IX encoding nucleotides | |
| US12274757B2 (en) | Recombinant adeno-associated viruses encoding serpin peptides and uses thereof | |
| US20250144243A1 (en) | Aav capsids for improved heart transduction and detargeting of liver | |
| EP4684808A1 (en) | Plasmids, transgenes, vectors and medical uses comprising adamts13 | |
| US12583907B2 (en) | Modified plasma clotting factor VIII and method of use thereof | |
| US20240076691A1 (en) | Codon-optimized nucleic acid encoding the fix protein | |
| JP2024511851A (ja) | 改変血漿凝固第viii因子およびその使用方法 | |
| OA21369A (en) | Codon-optimized nucleic acid encoding the fix protein. | |
| Mcintosh et al. | Factor VIII sequences | |
| GB2576508A (en) | Factor IX encoding nucleotides |